Ayesha Hinton Nutt
Family · Clinton, SCNPI 1275948838
Payments from drug & device makers
Across 242 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$445
- Novo Nordisk$383
- Lilly USA, LLC$324
- Amgen$319
- AbbVie$285
- GSK$254
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,866100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 22 | $445 |
| Novo Nordisk | 26 | $383 |
| Lilly USA, LLC | 25 | $324 |
| Amgen | 16 | $319 |
| AbbVie | 23 | $285 |
| GSK | 15 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $187 |
| Bayer | 11 | $155 |
| AstraZeneca | 11 | $148 |
| Amarin Pharma, Inc. | 9 | $142 |
| Novartis | 7 | $131 |
| Boehringer Ingelheim | 8 | $127 |
| Daiichi Sankyo Inc. | 5 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $108 |
| Eisai Inc. | 7 | $99 |
| Pfizer | 6 | $82 |
| Johnson & Johnson | 4 | $51 |
| Merck | 4 | $47 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| Antares Pharma, Inc. | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Exact Sciences | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $26 |
| Sanofi-aventis U.S. LLC | 2 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Philips North America LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Revance Therapeutics, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| Vistapharm, Inc. | 1 | $12 |
How this compares
$3,866 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $409 |
| Oxycodone Hcl | 11 | $373 |
| Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide | 11 | $361 |
| Levothyroxine Sodium | 18 | $231 |
| Pravastatin Sodium | 12 | $193 |
| Duloxetine Hcl | 15 | $159 |
| Rosuvastatin Calcium | 22 | $143 |
| Pantoprazole Sodium | 11 | $123 |
| Omeprazole | 18 | $121 |
| Metoprolol Succinate | 12 | $108 |
| Amlodipine Besylate | 19 | $104 |
| Simvastatin | 11 | $85 |
| Metformin Hcl | 11 | $84 |
| Hydrochlorothiazide | 12 | $74 |
| Lisinopril | 14 | $66 |
Paid to pharmacies, not to this prescriber.
Other family in Clinton
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.